Evidence map›Paper›PMID 41035958›Full record

ArticleFrontiers in psychiatry2025

Predictors for readmission risk in schizophrenia: insights from a Saudi Arabian cohort.

Mahmoud A Alharthi, Rajaa M Al-Raddadi, Sulhi A Alfakeh

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mahmoud A AlharthiPopulation Health Management, Jeddah First Health Cluster, Jeddah, Saudi Arabia.
Rajaa M Al-RaddadiDepartment of Community Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Sulhi A AlfakehPsychiatry Division, Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The readmission of individuals with schizophrenia to inpatient care can pose significant challenges and disturb the lives of both patients and their families, as well as the functioning of mental health care systems. Despite the growing prevalence of schizophrenia, there is limited research focused on the predictors of readmission within the Saudi Arabian context. Objectives: The primary objective of this research is to assess the readmission rate for patients who have been diagnosed with schizophrenia, as well as to determine the associations between socio-demographic factors and the risk of readmission for these patients. Methodology: In a retrospective cohort study, 145 individuals who were admitted to the Eradah and Mental Health complex in Jeddah since July 1st to December 31st in 2018 were recruited. Data on socio-demographic characteristics, medical history, medication adherence, and follow-up care were analyzed to determine their association with one-year readmission rates. Results: Findings revealed that male participants comprise 84.8% of the sample size. Moreover, 5.5% of the patients were employed, with the larger proportion being unemployed. The overall one-year readmission rate was 36.6%. The Key predictor of readmission included the number of previous admissions, length of hospital stay and frequency of outpatient follow-up visits. After controlling to other variables in a multivariate model, the length of stay was not statistically significant, despite appearing to be related to readmission in the unadjusted analysis. The probability of readmission was significantly increased by inadequate follow-up, illustrating the vital role of continuous post- discharge care. Conclusions: According to recent research, improving the transfer from inpatient psychiatric care to outpatient care may lower the risk of readmissions and prevent future hospitalization. The results emphasize the importance of specific treatments in minimizing readmission rates among schizophrenia patients in Saudi Arabia.

Indexed as

length of staymental healthpatient readmissionpsychiatric departmentretrospective studiesSaudi Arabiaschizophrenia

Identifiers

PMID41035958
PMCPMC12479423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.